Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Substitution of Subcutaneous Abatacept for Belatacept as Costimulation Blockade to Minimize Calcineurin Inhibitors (CNI) Exposure After Kidney Transplantation

NCT05975450 is registered in ClinicalTrials.gov with Idelberto Badell as lead sponsor.

NCT NCT05975450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05975450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Substitution of Subcutaneous Abatacept for Belatacept as Costimulation Blockade to Minimize Calcineurin Inhibitors (CNI) Exposure After Kidney Transplantation
Lead sponsor
Idelberto Badell
Phase
Phase 1
Overall status
Completed
Start date
August 2, 2023
Completion date
February 14, 2025
Enrollment
16 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant recipient